|New Center to Map DNA of Key Lab Mice
Research Triangle Park, NC – The National Institute of Environmental
Health Sciences will invest $13 million to map the DNA of 15 mouse
strains important to laboratory research on human health. This initiative,
called the “Resequencing Project” will launch the Institute’s
Center for Rodent Genetics.
The Center for Rodent Genetics is an extension of the Institute’s
ongoing research to understand the genetic basis for differences
in response to drugs and other environmental factors. Other initiatives
include the Environmental Genome Project and the National Center
“The Resquencing Project has attracted world-wide interest
and generated a lot of enthusiasm within the research community,”
said Kenneth Olden, PhD., director of NIEHS, one of the National
Institutes of Health. “Because the mouse strains will be sequenced
in parallel, inter-strain comparison will begin right away, and
their entire genomes will be complete within the next two years.”
Mouse strains slated for sequencing include: 129S1/SvImJ, A/J,
AKR/J, BALB/cByJ, BTBR T+ tf/J, C3H/HeJ, CAST/EiJ, DBA/2J, FVB/NJ,
MOLF/EiJ, KK/HlJ, NOD/LtJ, NZW/LacJ, PWD/PhJ, and WSB/EiJ. Since
these strains will be sequenced in reference to C57BL/6J, this project
will yield extensive DNA information on a total of 16 strains.
“Knowing the organization of the mouse genome is a key component
to identifying which gene-environment interactions are linked to
disease in humans,” said Dr. William Schrader, Director of
the Center. “We’ll start by mapping the DNA of 15 strains
of mice most often used by researchers to study susceptibility to
specific diseases. Then we can determine which diseases develop
because of exposure to factors in the environment.”
Almost all human genes have counterparts in mice. By examining
the environmental triggers of disease in genetically distinct mice,
researchers can gain a better understanding of the relationship
between genes and the environment in the development of disease
in humans. Almost 200 human diseases are affected by exposure to
environmental substances. For most diseases, more than one gene
is involved and researchers must discover the complex interplay
among genes in order to understand how diseases develop.
Examples of diseases targeted for study include: cancer, Parkinson’s,
Alzheimer’s, asthma, and developmental disorders such as autism.
Researchers already have identified dozens of genetic components
to these disorders, but few well-established animal models are available
for understanding the interplay of genes and environment. Therefore,
in addition to conducting the Resequencing Project, the Center for
Rodent Genetics will build a web-based storehouse of mouse research
models accessible to scientists throughout the world.
“The data base will allow scientists to pin-point the models
most useful for their own research and will allow them to focus
their work on the more likely genetic links to disease,” said
Dr. Olden. “This will help us identify the causes of disease
faster and will make research and drug development more cost effective.”
The Resequencing Project, which will be conducted through a 2-year
contract with Perlegen Sciences, Inc. of Mountain View, CA, is a
foundational effort in a long-term plan. For the first five years,
the Center for Rodent Genetics will foster efforts to investigate
environmental exposures and disease susceptibility, identify disease
mechanisms and pathways, compare mouse and human biomarkers, and
encourage development of rapid cell-based methods for comparing
the effects of environmental exposures. By the third year, the Center
will begin translating research findings to population analysis
and to toxicology testing. These studies will also influence the
development of curative treatment and regulatory decisions.
“Before genetic mapping, we were able to expose a mouse to
environmental toxins and see ‘if’ a disease developed,
but with genetic information, we can also understand ‘why’
a disease develops,” said Olden. “Technology is accelerating
both toxicology and environmental health research. NIEHS will lead
the way in these two disciplines to make predictions about disease.”
The Center for Rodent Genetics will compile the results of genetic
research on mice being conducted by several divisions within NIEHS.
It also will align with other research initiatives within the National
Institutes of Health that use genetically-modified organisms.
“We are not carrying out this work alone. We’re coordinating
our work to complement other projects, especially the Human Genome
Project, which is where we expect to see the most return on our
investment,” said Dr. Schrader.
The National Institute of Environmental Health Sciences supports
research to understand the effects of the environment on human health.